U.S. Paper and Forestry Products Stock News

NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

A Look At Monte Rosa Therapeutics (GLUE) Valuation After Strong Recent Share Price Momentum

Recent performance snapshot Monte Rosa Therapeutics (GLUE) has drawn investor attention after recent share price moves, with the stock last closing at $19.81 and delivering a return of 15.7% over the past month. See our latest analysis for Monte Rosa Therapeutics. While the recent 15.7% one-month share price return has been strong, the 29.4% year-to-date share price return and very large one-year total shareholder return suggest that momentum has been building over a longer period. If you are...
NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Upwork (UPWK) Margin Compression To 14.7% Tests Bullish Undervaluation Narrative

Upwork (UPWK) has just wrapped FY 2025 with fourth quarter revenue of US$198.4 million and basic EPS of US$0.12, alongside net income of US$15.6 million. This rounds out a year where trailing twelve month revenue came in at US$787.8 million and EPS at US$0.87. Over recent quarters the company has seen revenue move from US$191.5 million in Q4 2024 to between US$192.7 million and US$201.7 million across FY 2025, while quarterly EPS has ranged from US$0.12 to US$0.28. This sets up a story that...
NYSE:IVZ
NYSE:IVZCapital Markets

How Investors May Respond To Invesco (IVZ) Strong Q1 Results And New US$1 Billion Buyback Program

Invesco Ltd. has reported past first-quarter 2026 results showing revenue of US$1,744.5 million and net income of US$268.6 million, alongside higher earnings per share, increased common and preferred dividends, and ongoing share repurchases. The combination of stronger quarterly performance, continued net inflows, and the launch of a new US$1 billion buyback program highlights management’s focus on returning capital while growing assets under management. Next, we’ll examine how Invesco’s...
NYSE:NSC
NYSE:NSCTransportation

A Look At Norfolk Southern (NSC) Valuation After The Gainesville Inland Port Launch

The opening of the Gainesville Inland Port, with direct rail service from Norfolk Southern (NSC) five days a week, is drawing new attention to how this freight corridor could affect the stock. See our latest analysis for Norfolk Southern. The recent opening of the Gainesville Inland Port and Norfolk Southern's upcoming appearance at the Bank of America Industrials, Transportation & Airlines conference come against a backdrop of a 30 day share price return of 8.63% and a 1 year total...
NYSE:UNH
NYSE:UNHHealthcare

How UnitedHealth’s Margin Gains and Prior Authorization Cuts Could Impact UnitedHealth Group (UNH) Investors

In recent weeks, UnitedHealth Group reported Q1 2026 results showing revenues of US$111.70 billion and net earnings of US$6.48 billion, while also outlining portfolio divestitures, pending acquisitions, share repurchases, and plans to remove prior authorization requirements for a significant share of services by 2026. These moves, alongside improved margins, updated 2026 guidance and efforts to simplify care approvals, highlight how UnitedHealth is reshaping its operations to address cost...
NYSE:BMY
NYSE:BMYPharmaceuticals

EU Sotyktu Approval Tests Bristol-Myers Squibb’s Immunology And Earnings Story

European Commission approves Sotyktu (deucravacitinib) for adults with active psoriatic arthritis. First TYK2 inhibitor cleared for this indication in the European Union. Label expansion adds a once daily oral option for patients with limited treatment choices. Bristol-Myers Squibb (NYSE:BMY), trading at $56.25, now has an expanded EU label for Sotyktu that reflects its efforts in immunology. The stock is up 26.0% over the past year and 5.2% year to date, while longer multiyear returns have...
NYSE:NET
NYSE:NETIT

Cloudflare (NET) Q4 Loss Narrows Yet Ongoing TTM Losses Test Bullish Profitability Narrative

Cloudflare FY 2025 earnings snapshot Cloudflare (NET) has wrapped up FY 2025 with fourth quarter revenue of US$614.5 million and basic EPS of a US$0.03 loss, alongside a trailing twelve month revenue base of about US$2.2 billion and a net loss of US$102.3 million. Over recent periods the company has seen revenue move from US$430.1 million in Q3 2024 to US$614.5 million in Q4 2025, while quarterly basic EPS has ranged between a loss of US$0.15 and a loss of US$0.00, underscoring an ongoing...
NasdaqGS:ALGM
NasdaqGS:ALGMSemiconductor

How New Auto and Data Center Mix At Allegro MicroSystems (ALGM) Has Changed Its Investment Story

In early May 2026, Allegro MicroSystems reported past fourth-quarter and full-year results showing higher sales but continued net losses, while issuing first-quarter 2027 guidance for US$245 million to US$255 million in net sales, implying 23% year-over-year growth at the midpoint. The combination of strong automotive and rapidly expanding data center sales, alongside efforts to offset input cost pressures with copper wiring and surcharges, signals an evolving business mix focused on...
NasdaqGS:CZR
NasdaqGS:CZRHospitality

Will Caesars’ Narrowed Loss and New Venues Reshape Caesars Entertainment's (CZR) Investment Narrative?

In the first quarter of 2026, Caesars Entertainment reported higher sales of US$2,153 million and revenue of US$2,870 million, while reducing its net loss to US$98 million compared with the prior year. Alongside these improved results, Caesars has been expanding its entertainment offerings with new venues such as OMNIA Dayclub & Skybar in Las Vegas and the upcoming Caesars Beach Club in Atlantic City, aiming to draw more visitors to its properties. Next, we will examine how Caesars’ narrowed...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Does Milestone-Driven Profit Shift the Bull Case For Protagonist Therapeutics’ New Model (PTGX)?

Protagonist Therapeutics reported first-quarter 2026 results that swung to a net income of US$3.78 million, helped by a US$50 million milestone payment linked to FDA approval of ICOTYDE and a US$200 million payment from restructuring its rusfertide collaboration. These developments not only produced an unexpected profit but also shifted Protagonist’s business model toward milestone- and royalty-based revenues backed by liquidity of about US$620.3 million. Next, we’ll examine how this move...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex’s German CASGEVY Deal And The Push Beyond Cystic Fibrosis

Vertex Pharmaceuticals (NasdaqGS:VRTX) has secured a reimbursement agreement in Germany for its CASGEVY gene therapy for sickle cell disease and beta thalassemia. This is Germany's first long term access deal for a gene edited therapy of this kind, supporting broader patient access within the country. The agreement expands CASGEVY access in Europe and adds to Vertex's efforts to build revenue beyond its cystic fibrosis portfolio. For investors tracking NasdaqGS:VRTX, the new German...
NYSE:CNC
NYSE:CNCHealthcare

How Strong Q1 2026 Results and Higher Guidance Will Impact Centene (CNC) Investors

In the first quarter of 2026, Centene Corporation reported revenue of US$49.94 billion and net income of US$1.54 billion, with diluted EPS from continuing operations of US$3.11, all higher than a year earlier. Alongside these results, Centene raised its 2026 guidance, lifting expected total revenue to between US$187.50 billion and US$191.50 billion and increasing its GAAP diluted EPS outlook to above US$2.37, signaling management’s confidence in ongoing margin and cost initiatives. We’ll now...
NYSE:MKL
NYSE:MKLInsurance

How Investors May Respond To Markel Group (MKL) Activist Push To Spin Off Ventures And Buy Back Stock

In late April 2026, JANA Partners sent a letter to Markel Group’s board urging a divestiture of Markel Ventures and a US$2.00 billion share repurchase tender, while questioning incentive payouts and arguing that the Ventures segment has diluted the value of the core insurance business. This activist push brings Markel’s long-standing “forever home” pledge to acquired businesses into direct tension with shareholder priorities around capital allocation and corporate structure. We’ll now...
NasdaqGS:VRNS
NasdaqGS:VRNSSoftware

Varonis Systems (VRNS) Is Up 9.0% After AI-Fueled Beat, Buyback Completion And Raised 2026 Outlook

In late April 2026, Varonis Systems reported first-quarter revenue of US$173.13 million, a similar loss per share as a year earlier, completed a US$149.99 million buyback program, and issued guidance calling for double-digit revenue growth for the second quarter and full year 2026. At the same time, Varonis highlighted surging demand for its AI and data security platform, including new ENS High certification in Spain and stronger SaaS adoption, reinforcing its role in securing the data that...
NYSE:WTM
NYSE:WTMInsurance

Why Is White Mountains (WTM) Accepting Ark Strength While MediaAlpha Marks Drive a Quarterly Loss?

White Mountains Insurance Group reported first-quarter 2026 results showing revenue of US$517.8 million and a net loss of US$27.2 million, reversing a profit a year earlier as investment losses pushed basic and diluted loss per share from continuing operations to US$12.59. Beneath the headline loss, the company’s Ark/WM Outrigger insurance operations produced strong underwriting results, while a large unrealized loss on its MediaAlpha stake and a 1% decline in book value per share...
NYSE:VIK
NYSE:VIKHospitality

Viking Expands 2028–2029 Expeditions As Premium Growth Story Builds

Viking Holdings (NYSE:VIK) opened bookings for its expanded 2028–2029 expedition voyages. The company added new departure dates and extra sailings in the Arctic, Antarctica, and the Great Lakes. The move widens Viking's expedition footprint across remote and cold-weather destinations. Viking Holdings, listed as NYSE:VIK, focuses on premium cruises, including ocean, river, and expedition offerings. The decision to expand expedition sailings in 2028 and 2029 in the Arctic, Antarctica, and the...
NYSE:HIMS
NYSE:HIMSHealthcare

A Look At Hims & Hers Health (HIMS) Valuation As Earnings Scrutiny And Legal Risks Intensify

Hims & Hers Health (HIMS) heads into its May 11 earnings report under closer watch as investors weigh margin concerns, rising competitive and legal pressures, and recent board changes that reshape the company’s governance profile. See our latest analysis for Hims & Hers Health. Short term sentiment has cooled, with a 1 day share price return showing a decline of 4.58% and a 7 day share price return showing a decline of 5.59%. However, the 30 day share price return of 31.54% and multi year...
NYSE:ANET
NYSE:ANETCommunications

Arista Networks (ANET) Is Down 17.9% After Raising 2026 Revenue Outlook Amid AI-Driven Demand

In early May 2026, Arista Networks reported first-quarter revenue of US$2,709 million and net income of US$1,022.9 million, and guided second-quarter revenue to about US$2.8 billion while raising its full-year 2026 revenue outlook to roughly US$11.5 billion despite industry-wide supply constraints pressuring margins. The results underscored how surging demand for Arista’s AI-focused networking platforms, including its 7800 AI spine and universal AI fabric offerings, is helping the company...
NYSE:PAGS
NYSE:PAGSDiversified Financial

Does Softer EPS Estimates Amid Expected Growth Change The Bull Case For PagSeguro Digital (PAGS)?

In early May 2026, attention turned to PagSeguro Digital as analysts anticipated year-over-year increases in earnings per share and revenue for the March 2026 quarter, even as earnings estimates were revised slightly lower. This mix of expected operational improvement and cautious analyst revisions has put extra focus on how reliably PagSeguro can translate growth into consistent performance versus forecasts. With analysts expecting higher earnings and revenue despite slightly lower...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Is It Time To Reassess Adobe (ADBE) After Its Recent Share Price Slump?

If you are wondering whether Adobe's current share price really reflects what the stock could be worth, this breakdown will help you weigh up the numbers behind that question. Adobe closed at US$256.51, with returns of 4.2% over the last week and 6.8% over the last month, while the year-to-date return stands at a 23.0% decline and the 1-year return at a 33.2% decline. Recent moves in the stock sit alongside ongoing attention on Adobe's position in creative software and digital media, as...
NYSE:GME
NYSE:GMESpecialty Retail

GameStop CEO Account Suspension Adds New Questions For eBay Bid Investors

GameStop CEO Ryan Cohen reportedly had his personal eBay account suspended after listing GameStop themed items for auction. The auctions came while GameStop is pursuing an unsolicited takeover bid for eBay, creating an unusual overlap between a live offer and a CEO's personal activity. The episode adds a new wrinkle to an already tense situation between the two companies. For investors watching NYSE:GME, this episode lands on top of an already volatile share price history. The stock last...
NYSE:RKT
NYSE:RKTDiversified Financial

Rocket Companies (RKT) Swings To Q4 Profit And Tests Bullish Turnaround Narrative

Rocket Companies (RKT) closed FY 2025 with fourth quarter revenue of US$2.8b, basic EPS of US$0.02 and net income of US$68.0m, setting a clear marker for how the year wrapped up. Over recent periods the company has seen quarterly revenue move from US$1.9b in Q4 2024 to US$2.8b in Q4 2025, while basic EPS shifted from US$0.23 to US$0.02, and net income moved from US$33.5m to US$68.0m. This provides a clear view of how the top and bottom lines translated into current margins and overall...
NasdaqGM:INOD
NasdaqGM:INODProfessional Services

Innodata (INOD) Margin Compression Challenges Bullish AI Growth Narrative After FY 2025 Results

Innodata (INOD) just wrapped up FY 2025 with fourth quarter revenue of US$72.4 million and basic EPS of US$0.28, while trailing twelve month revenue came in at US$251.7 million and basic EPS at US$1.01. Over recent quarters the company has seen revenue move from US$59.2 million in Q4 2024 to US$72.4 million in Q4 2025, with basic EPS shifting from US$0.34 to US$0.28 over the same period. This sets up a picture where growth expectations and margin trends will be front of mind for investors...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Cerence Lawsuit Puts Amazon Conversational AI And Device Growth Under Scrutiny

Cerence Inc. has filed a patent infringement lawsuit against Amazon.com and its subsidiaries, targeting core conversational AI technology used in Amazon smart devices. The company is asking the U.S. International Trade Commission to block the importation of certain Amazon smart speakers, displays, tablets, and streaming devices that allegedly infringe its patents. The action focuses on foundational voice and conversational AI capabilities that sit at the center of Amazon's connected device...